The analysis suggested that the improved endothelial function and reduced arterial stiffness associated with SGLT2-i could potentially lower the incidence of restenosis and the need for subsequent revascularization procedures in PAD patients. This evidence concerns the gene SLC5A2 and peripheral arterial disease.